ABBOTT LABORATORIES — Director's Dealing 2009

Feb 11, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2009-02-06

Reporting Person: Chen Thomas F (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-02-06	Common shares without par value	M	1840	$54.30	Acquired	81701	Direct
2009-02-06	Common shares without par value	S	1840	$57.002	Disposed	79861	Direct
2009-02-06	Common shares without par value	M	3050	$33.2314	Acquired	82911	Direct
2009-02-06	Common shares without par value	F	1792	$56.53	Disposed	81119	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-02-06	Options (right to buy)	$54.30	M	1840	Disposed	2009-02-11	Common shares (1840)	Direct
2009-02-06	Options (right to buy)	$33.2314	M	3050	Disposed	2013-02-13	Common shares (3050)	Direct
2009-02-06	Option (right to buy)	$56.53	A	1792	Acquired	2013-02-13	Common shares (1792)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	17871	Indirect
Common shares without par value	23798	Indirect
Common shares without par value	610	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 6, 2009.

F2: The reporting person disclaims beneficial ownership of all securities held by his wife and daughter.

F3: Employee stock option, including replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.